Xianmei WU, Junli LUO, Wenxiang HUANG, et al. Role of ascitic endocan level in diagnosis of spontaneous bacterial peritonitis in patients with cirrhotic ascites[J]. Journal of Third Military Medical University, 2020, 42(13): 1338-1344.
DOI:
Xianmei WU, Junli LUO, Wenxiang HUANG, et al. Role of ascitic endocan level in diagnosis of spontaneous bacterial peritonitis in patients with cirrhotic ascites[J]. Journal of Third Military Medical University, 2020, 42(13): 1338-1344. DOI: 10.16016/j.1000-5404.202002092.
Role of ascitic endocan level in diagnosis of spontaneous bacterial peritonitis in patients with cirrhotic ascites
To explore the role of ascitic endocan level in the diagnosis of spontaneous bacterial peritonitis (SBP) in the patients with cirrhotic ascites.
Methods
2
A total of 161 ascitic patients with decompensated cirrhosis admitted to our hospital from January 2018 to June 2019 were recruited in this study
and 35 of them suffered from SBP and served as SBP group
and the other 126 as non-SBP group. Ascitic samples were obtained at admission. Demographic data and laboratory parameters were collected. The ascitic endocan level was measured by ELISA. Logistic regression analysis was used to analyze the independent influencing factors for SBP
and receiver operating characteristic (ROC) curve were used to analyze the diagnostic value of ascitic endocan level for SBP.
Results
2
The level of ascitic endocan was significantly higher in the SBP group than the non-SBP group. Logistic regression analysis showed that the ascitic endocan level was an independent risk factor for SBP (
OR
=1.008
95%
CI
: 1.004~1.012
P
<
0.001). The result of ROC curve indicated that the area under the curve (AUC) of ascitic endocan was 0.822 (
P
<
0.001)
and the sensitivity was 88.57% and the specificity was 70.63% when the cut-off value was 280.983 pg/mL. The AUCs of ascitic endocan for the diagnosis of SBP were 0.852 and 0.789 respectively in the patients older or equal to 60 and younger than 60 years.
Conclusion
2
The ascitic endocan level is an independent risk factor for SBP in patients with cirrhotic ascites
and may serve as a valuable biomarker for diagnosis of SBP
especially in those aged 60 or older.
关键词
Keywords
references
TSIAOUSSIS G I, ASSIMAKOPOULOS S F, TSAMANDAS A C, et al . Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications[J ] . World J Hepatol, 2015, 7(17): 2058-2068. DOI:10.4254/wjh.v7.i17.2058.
SIPEKI N. Immune dysfunction in cirrhosis[J]. World J Gastroenterol, 2014, 20(10): 2564. DOI:10.3748/wjg.v20.i10.2564.
APPENRODT B, GRVNHAGE F, GENTEMANN M G, et al . Nucleotide-binding oligomerization domain containing 2(NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis[J ] . Hepatology, 2010, 51(4): 1327-1333. DOI:10.1002/hep.23440.
MAI M, STENGEL S, AL-HERWI E, et al . Genetic variants of TRAF6 modulate peritoneal immunity and the risk of spontaneous bacterial peritonitis in cirrhosis: a combined prospective-retrospective study[J ] . Sci Rep, 2017, 7(1): 4914. DOI:10.1038/s41598-017-04895-z.
[ARVANITI V, D'AMICO G, FEDE G, et al . Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis[J ] . Gastroenterology, 2010, 139(4): 1246-1256, 1256.e1-5. DOI: 10.1053/j.gastro.2010.06.019 http://dx.doi.org/10.1053/j.gastro.2010.06.019 ..
SINGAL A K, SALAMEH H, KAMATH P S. Prevalence and in-hospital mortality trends of infections among patients with cirrhosis: a nationwide study of hospitalised patients in the United States[J]. Aliment Pharmacol Ther, 2014, 40(1): 105-112. DOI:10.1111/apt.12797.
WIEST R, KRAG A, GERBES A. Spontaneous bacterial peritonitis: recent guidelines and beyond[J]. Gut, 2012, 61(2): 297-310. DOI:10.1136/gutjnl-2011-300779.
FERNÁNDEZ J, ACEVEDO J, CASTRO M, et al . Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study[J ] . Hepatology, 2012, 55(5): 1551-1561. DOI:10.1002/hep.25532.
BIECKER E. Diagnosis and therapy of ascites in liver cirrhosis[J]. World J Gastroenterol, 2011, 17(10): 1237. DOI:10.3748/wjg.v17.i10.1237.
BÉCHARD D, SCHERPEREEL A, HAMMAD H, et al . Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1[J ] . J Immunol, 2001, 167(6): 3099-3106. DOI:10.4049/jimmunol.167.6.3099.
KALI A, SHETTY K S. Endocan: a novel circulating proteoglycan[J]. Indian J Pharmacol, 2014, 46(6): 579-583. DOI:10.4103/0253-7613.144891.
LASSALLE P, MOLET S, JANIN A, et al . ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines [J ] . J Biol Chem, 1996, 271(34): 20458-20464. DOI:10.1074/jbc.271.34.20458.
SEO K, KITAZAWA T, YOSHINO Y, et al . Characteristics of serum endocan levels in infection[J ] . PLoS ONE, 2015, 10(4): e0123358. DOI:10.1371/journal.pone.0123358.
SCHERPEREEL A, DEPONTIEU F, GRIG OR IU B, et al . Endocan, a new endothelial marker in human sepsis[J ] . Crit Care Med, 2006, 34(2): 532-537. DOI:10.1097/01.ccm.0000198525.82124.74..
HSIAO S Y, KUNG C T, TSAI N W, et al . Concentration and value of endocan on outcome in adult patients after severe sepsis[J ] . Clin Chim Acta, 2018, 483: 275-280. DOI:10.1016/j.cca.2018.05.007.
ZUWALA-JAGIELLO J, SIMON K, KUKLA M, et al . Increased circulating endocan in patients with cirrhosis: relation to bacterial infection and severity of disease[J ] . J Physiol Pharmacol, 2017, 68(2): 273-282.
European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis[J]. J Hepatol, 2010, 53(3): 397-417. DOI:10.1016/j.jhep.2010.05.004.
PLEGUEZUELO M, BENITEZ J M, JURADO J, et al . Diagnosis and management of bacterial infections in decompensated cirrhosis[J ] . World J Hepatol, 2013, 5(1): 16-25. DOI:10.4254/wjh.v5.i1.16.
SCHWABL P, BUCSICS T, SOUCEK K, et al . Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites[J ] . Liver Int, 2015, 35(9): 2121-2128. DOI:10.1111/liv.12795.
BURRI E, SCHULTE F, MUSER J, et al . Measurement of calprotectin in ascitic fluid to identify elevated polymorphonuclear cell count[J ] . World J Gastroenterol, 2013, 19(13): 2028-2036. DOI:10.3748/wjg.v19.i13.2028.
PARSI M A, SAADEH S N, ZEIN N N, et al . Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitis[J ] . Gastroenterology, 2008, 135(3): 803-807. DOI:10.1053/j.gastro.2008.05.045.
PAN H Y, SUN H Y, CHEN C R, et al . Determination of ascitic bacterial 16S rRNA gene in the rapid diagnosis of spontaneous bacterial peritonitis[J ] . Acta Acad Med Sin, 2010, 32(5): 557-560. DOI:10.3881/j.issn.1000-503X.2010.05.017.
MENDLER M H, AGARWAL A, TRIMZI M, et al . A new highly sensitive point of care screen for spontaneous bacterial peritonitis using the leukocyte esterase method[J ] . J Hepatol, 2010, 53(3): 477-483. DOI:10.1016/j.jhep.2010.04.011.
BOARETTI M, CASTELLANI F, MERLI M, et al . Presence of multiple bacterial markers in clinical samples might be useful for presumptive diagnosis of infection in cirrhotic patients with culture-negative reports[J ] . Eur J Clin Microbiol Infect Dis, 2016, 35(3): 433-441. DOI:10.1007/s10096-015-2556-x.
RUNYON B A. Strips and tubes: improving the diagnosis of spontaneous bacterial peritonitis[J]. Hepatology, 2003, 37(4): 745-747. DOI:10.1053/jhep.2003.50178.
RUNYON B A. The evolution of ascitic fluid analysis in the diagnosis of spontaneous bacterial peritonitis[J]. Am J Gastroenterol, 2003, 98(8): 1675-1677. DOI:10.1111/j.1572-0241.2003.07600.x.
Chinese Soc iety of Hepatology of Chinese Medical Association, XU X Y, DUAN Z P, et al . Chinese guidelines on the management of ascites and its related complications in cirrhosis[J ] . Hepatol Int, 2019, 13(1): 1-21. DOI:10.1007/s12072-018-09923-2.
GAUDET A, CHENEVIER-GOBEAUX C, PARMENTIER E, et al . Endocan is a stable circulating molecule in ICU patients[J ] . Clin Biochem, 2017, 50(15): 870-877.DOI:10.1016/j.clinbiochem.2017.04.011.
AFSAR B, TAKIR M, KOSTEK O, et al . Endocan: a new molecule playing a role in the development of hypertension and chronic kidney disease?[J ] . J Clin Hypertens (Greenwich), 2014, 16(12): 914-916. DOI:10.1111/jch.12440.
Diagnostic value of endoscopic LCPL sign for high-risk intestinal metaplasia in gastric mucosa
Construction of a diagnostic model for chronic mountain sickness among young male migrants to high-altitude areas
Value of natural orifice transluminal endoscopic surgery in diagnosis of unexplained ascites
Radial probe endobronchial ultrasound-guided bronchoscopy for peripheral pulmonary lesions
Value of an ultrasonographic scoring system in diagnosis of Sjögren's syndrome
Related Author
ZHENG Xipeng
PAN Huilin
WU Linyu
HOU Yongying
LIU Qin
MA Qiang
QIN Xiuyuan
LIU Kaijun
Related Institution
Department of Gastroenterology, Chongqing Key Laboratory of Precise Prevention and Treatment of Digestive Malignancies
Department of Pathology, Army Medical Center of PLA/Daping Hospital of Third Military Medical University, Chongqing
First Clinical College of Chongqing Medical University
Department of High Altitude Physiology and Pathology, Faculty of High Altitude Military Medicine, Army Medical University (Third Military Medical University)
Department of Medicine and Hygienic Equipment for High Altitude Region, Faculty of High Altitude Military Medicine, Army Medical University (Third Military Medical University)